![[ICO]](/icons/blank.gif){kind=icon}
![[PARENTDIR]](/icons/back.gif){kind=icon}
![[ ]](/icons/unknown.gif){kind=icon}
![[DIR]](/icons/folder.gif){kind=icon}
![[IMG]](/icons/image2.gif){kind=icon}
![[ ]](/icons/layout.gif){kind=icon}
![[TXT]](/icons/text.gif){kind=icon}
![[ ]](/icons/compressed.gif){kind=icon}
| Name | Last modified | Size | Description |
|---|---|---|---|---|
| Parent Directory | - | ||
| 58617_DW.docx | 2018-10-03 12:06 | 26K | |
| 58617_Lee_Voiceover/ | 2018-10-05 03:19 | - | |
| 58617_R1.docx | 2018-10-03 12:06 | 123K | |
| 58617fig1.jpg | 2018-08-14 21:58 | 234K | |
| 58617fig1large.jpg | 2018-08-14 21:58 | 969K | |
| 58617fig2.jpg | 2018-08-14 21:58 | 111K | |
| 58617fig2large.jpg | 2018-08-14 21:58 | 500K | |
| 58617fig3.jpg | 2018-08-14 21:58 | 172K | |
| 58617fig3large.jpg | 2018-08-14 21:58 | 564K | |
| 58617fig4.jpg | 2018-08-14 21:58 | 125K | |
| 58617fig4large.jpg | 2018-08-14 21:58 | 734K | |
| 58617fig5.jpg | 2018-08-14 21:58 | 46K | |
| 58617fig5large.jpg | 2018-08-14 21:58 | 220K | |
| Author_License_Agree..> | 2018-10-03 12:06 | 213K | |
| Figure 1.pdf | 2018-10-03 12:06 | 25K | |
| Figure 2 Edit.pdf | 2018-10-03 12:06 | 32K | |
| Figure 3.pdf | 2018-10-03 12:06 | 291K | |
| Figure 4.pdf | 2018-10-03 12:06 | 60K | |
| Figure 5.pdf | 2018-10-03 12:06 | 21K | |
| JoVE58617.pdf | 2018-10-03 12:06 | 4.4M | |
| JoVE58617.xml | 2018-10-03 12:06 | 16K | |
| JoVE Resubmission Ed..> | 2018-10-03 12:06 | 8.6M | |
| Jove_Carey et al.doc | 2018-10-03 12:06 | 153K | |
| Materials List JoVE ..> | 2018-10-03 12:06 | 16K | |
| Table 1 CVS Regimen...> | 2018-10-03 12:06 | 9.2K | |
| Table 2 Sequencing M..> | 2018-10-03 12:06 | 9.8K | |
| Table 3 List of DMRs..> | 2018-10-03 12:06 | 11K | |
| Table 4 KEGG Pathway..> | 2018-10-03 12:06 | 10K | |
| jove_JoVE58617.zip | 2018-10-03 12:06 | 5.2M | |